AzurRx BioPharma Inc (AZRX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

760 PARKSIDE AVENUE BROOKLYN, NY 11226

AzurRx BioPharma, Inc. operates as a development stage biopharmaceutical company. The Company focuses on the research and development of recombinant proteins for the treatment of patients with gastrointestinal disorders and microbiome related conditions.

Data as of 2020-11-22
Market Cap22.09 Million Shares Outstanding30.412 Million Avg 30-day Volume134.271 Thousand
P/E Ratio-1.4 Dividend Yield EPS-0.56
Price/Sales Price cash flow ratio Price free cash flow ratio-4.0
Book Value0.46 Price to Tangible Book-4.04 Alpha-0.04
Short Interest Ratio % Short Interest to Float R-squared0.142866
BETA1.83304 52-week High/Low1.9383 / 0.370868 Stddev0.218155
View SEC Filings from AZRX instead.
Q3 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 18 17 5.88% 3 (0.2%) 5 (0.32%) -40.0%
13F shares: 1.563 Million 1.405 Million 11.25% 112.448 Thousand 319.484 Thousand -64.8%
% Ownership 5.4848 4.9302 11.25% 0.3945 1.1209 -64.81%
New Positions: 5 3 66.67% 1 1 0.0%
Increased Positions 4 5 -20.0% 1
Closed Positions 4 5 -20.0% 3 2 50.0%
Reduced Positions 2 4 -50.0%
Total Calls 0
Total Puts 0
PUT/CALL Ratio
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding AZRX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AZRX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

BORKOWSKI EDWARD

0 2020-07-16 5

PENNINGTON JAMES CHIEF MEDICAL OFFICER

0 2020-07-16 1

SAPIRSTEIN JAMES PRESIDENT AND CEO

0 2020-07-16 1

SCHNEIDERMAN DANIEL H CHIEF FINANCIAL OFFICER

0 2020-07-16 3

OAKES GREGORY

0 2020-04-13 2

SPOOR JOHAN M.

0 2020-04-06 1

RIDDELL ALASTAIR

0 2020-04-06 3

CASAMENTO CHARLES J

0 2020-04-06 4

SCHRAMM VERN LEE

0 2020-04-06 3

ROSS EDMUND BURKE JR.

0 2020-01-02 1

SHENOUDA MAGED CHIEF FINANCIAL OFFICER

62,500 2018-12-28 0

DUPRET DANIEL CHIEF SCIENTIFIC OFFICER

15,000 2018-07-12 0

PELICAN PARTNERS LLC

BALK MATTHEW

  • 10% Owner
1,727,796 2017-06-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

Elevate your investments